|
FDA May Reinstate Oversight Policy as Warning Letter Quality Declines
Since FDA Commissioner Margaret Hamburg ended prior legal review of warning letters last summer, their quality has declined, industry says, prompting the agency to evaluate the policy change.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives